-
Taxonomy & unit
-
dei: USD
-
Description
-
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
-
Summary
-
Regeneron Pharmaceuticals, Inc. quarterly Entity Public Float history and growth rate from Q4 2010 to Q2 2023.
- Regeneron Pharmaceuticals, Inc. Entity Public Float for the quarter ending June 30, 2023 was $76.7B, a 23.7% increase year-over-year.
Entity Public Float, Quarterly (USD)
Entity Public Float, YoY Quarterly Growth (%)